Search

CPD and Education library

Study and gain CPD points through OT’s online CPD exams, and access archived CPD and CET articles, Practice team resources and Skills guides in our Education library

Find out more

Science and vision

News and features about the latest scientific developments and advances in optometry, ophthalmology and eye medicine

Find out more

Industry

News and features about the latest developments in optics with a focus on industry

Find out more

Professional support

News and features about the latest developments relating to professional support from across optics. This includes updates from optical organisations such as the AOP and the GOC

Find out more

In practice

News and in-depth features about business management and career development in optics

Find out more

Jobs

Explore the latest UK and global jobs in the optical sector for optometrists, dispensing opticians and more

Find out more

Scientists trial berry extract as treatment for eye cancer

A compound from the Christmas berry primrose plant is being explored as a potential therapeutic option for uveal melanoma

Christmas berry primrose plant

Scientists are exploring the potential of a berry extract as a way of preventing a common form of adult eye cancer from spreading.

In a new study, which was published in Molecular Cancer Research, researchers found that a compound extracted from the Christmas berry primrose plant inhibited the growth of uveal cancer in preliminary tests.

Scientists grew three different types of uveal melanoma cells in the lab then treated them with a compound extracted from the berry, FR900359 (FR).

Dr Jeffrey Benovic, from the Sidney Kimmel Cancer Center, said that the cells appeared to revert from cancer cells to typical melanocytes when exposed to the compound.

“FR appears to be able to help reset the cells back to their normal state,” he explained.

Higher doses of FR killed the cells, suggesting that the compound could be an effective treatment for uveal melanoma one day.

As a next step, the researchers plan on using FR in a mouse model of uveal melanoma.

Image credit: Dan Foy